A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Recruiting · NCT06844383 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-08-21 | NCT06844383 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Memorial Sloan Kettering Cancer Center | 753 |
| Pfizer | 431 |
| Prostate Cancer Clinical Trials Consortium | 7 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania | Philadelphia | United States | 1 |
| City of Hope | Duarte | United States | 238 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Masonic Cancer Center | Minneapolis | United States | 15 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| UCSD Moores Cancer Center | La Jolla | United States | 2 |
| University of Wisconsin Carbone Cancer Center-Madison | Madison | United States | 1 |